TORL BioTherapeutics, LLC
1 follower
A clinical-stage biopharmaceutical company advancing the development of new biologics for cancer treatment. TORL-Bio was founded in 2018 and is focused on the development of novel antibody-based therapeutics for cancer patients. TORL has currently 3 therapeutics in Ph1 clinical trials in indicatio... Read more
Org chart
Mark Alles
Chief Executive Officer
Mark Alles
Collapse
Stephen Letrent
Chief Development Officer
Dave Licata
President And CFO TORL Biotherapeutics / Executive Chairman 1200 Pharma
